New pharmacy player has big plans

Share this article:
A start-up institutional pharmacy company could soon become the market's No. 3 player, according to its executives. The parent group of Golden Living officially launched AlixaRx with predictions it could become a $250 million per year business within 18 months. Ultimately capturing one-fifth or more of the 16,000-nursing home market is a distinct possibility, said AlixaRx President Larry Deans: “If we had 20% of market share [within five years], right now that would be a good goal to shoot for. We believe providers have a need for this service.” AlixaRx's unveiling comes at the detriment of PharMerica, which is losing the Golden Living contracts, company officials said. PharMerica currently has about 20% of the long-term care institutional pharmacy market, which has put it second behind leader Omnicare, which commands approximately 60% of the market, Deans said.
Share this article:

More in Products

ACO white paper geared toward post-acute providers

A new white paper focuses on what kinds of services accountable care organizations should provide in the post-acute spectrum.

Accutech Security releases wander management system

Accutech Security releases wander management system

Accutech Security has released its new ResidentGuard LS 2400 wander management system, which can be used in senior living settings.

Sharps Compliance Corp. and MedReturn, LLC launch MedSafe

Sharps Compliance Corp. and MedReturn, LLC launch MedSafe

The Sharps Compliance Corp. and MedReturn LLC have created MedSafe, a system set up to dispose of unwanted and expired medications, including controlled substances.